Federal Supply Schedule 36F79721D0184
Award Date 6/15/21
Last Date to Order 12/31/21
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Other Statutory Authority
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed Similar IDVs
- This multiple award IDV was issued by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 to procure pharmaceuticals and drugs under GSA's Pharmaceuticals and Drugs Schedule. The prime contractor is Q Biomed Inc. With a potential value of $225,000 and a period of performance through February 2026, the contract aims to deliver 65 I B drugs, pharmaceuticals, and hematology-related products to VA medical treatment facilities in the region. The...
- This multiple award IDV was issued by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 to procure pharmaceuticals and drugs under GSA's Pharmaceuticals and Drugs schedule. The prime contractor is Akorn, Inc. With a potential value of $244,163,640 and a period of performance through June 2023, the IDV aims to facilitate orders for Schedule 65 IB products including drugs, pharmaceuticals, and hematology-related items to support VA...
- This multiple award IDV was issued by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 to procure pharmaceuticals and drugs under GSA's Pharmaceuticals and Drugs Schedule. Hill Dermaceuticals Inc. was awarded the IDV with a potential value of $225,000. No set-aside was used. Products and services must be delivered by January 14, 2023. The IDV aims to procure drugs, pharmaceuticals, and hematology-related products listed in GSA Schedule 65...
- This multiple award IDV was issued by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 to procure pharmaceuticals and drugs under GSA's Pharmaceuticals and Drugs Schedule. West Therapeutic Development, LLC was awarded the IDV as the prime contractor. The IDV aims to procure a range of drugs, pharmaceuticals, and hematology-related products over a four year period ending in January 2024, with a potential value of $225,000. No set-asides were...
- This multiple award IDV was issued by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 under the Pharmaceuticals and Drugs (FSS-61-IB) GSA Schedule. The contract aims to procure various drugs, pharmaceuticals, and hematology-related products through May 2023. Baudax Bio, Inc. is the prime contractor with a potential value of $620,400. The original solicitation sought drugs, pharmaceuticals, and related products to support the treatment of...
- This Federal Supply Schedule contract was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 to procure pharmaceuticals and drugs under GSA Schedule 65 IB. The multiple award contract has a potential value of $750,000 and a period of performance through July 31, 2026. The prime contractor is Myovant Sciences Inc., which will provide drugs, pharmaceuticals, and hematology-related products to support the VA's healthcare services...
- This multiple award IDV was issued by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 to acquire pharmaceuticals and drugs under GSA's Pharmaceuticals and Drugs schedule. Circassia Inc. was awarded the IDV with a potential value of $30.4 million and a period of performance through March 2025. The IDV facilitates the acquisition of drugs, pharmaceuticals, and hematology-related products through task orders or delivery orders issued...
- This Federal Supply Schedule contract was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 to Vantive US Healthcare LLC. The contract provides for drugs, pharmaceuticals, and hematology related products under Federal Supply Schedule 65 IB. With a potential value of $25,000 and a period of performance through August 2024, this multiple-award schedule aims to ensure Veterans receive needed medical supplies and treatments. The...
- The federal contract IDV award is a multiple award Federal Supply Schedule under the Pharmaceuticals and Drugs master schedule. The prime contractor is Epizyme, Inc., doing business as Epizyme. The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 is the contracting agency. The contract aims to procure drugs, pharmaceuticals, and hematology-related products through June 2023 for a potential value of $225,000. No set-asides were used. The...
- The federal contract IDV award is a Federal Supply Schedule (FSS) contract under Schedule 65 I B for Drugs, Pharmaceuticals, & Hematology Related Products. The contracting agency is the Veterans Integrated Service Network 12 (VISN 12), a civilian agency within the Department of Veterans Affairs. The prime contractor is Quallent Pharmaceuticals Health, LLC, a foreign-owned for-profit manufacturer of goods. The contract has a ceiling value of $25,000.00 and a period of performance through...